Andrew James King insider trades: Chinook Therapeutics (KDNY) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Andrew reports to the SEC
Open-market buys and sales
13 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 1, 2023 | KDNY | ↓ Sell | 1,168 | $39.03 | $46K | Direct | Aug 1, 2023 (0d) |
| Apr 3, 2023 | KDNY | ↓ Sell | 5,000 | $23.34 | $117K | Direct | Apr 5, 2023 (2d) |
| Feb 10, 2023 | KDNY | ↓ Sell | 2,392 | $23.75 | $57K | Direct | Feb 15, 2023 (5d) |
| Jan 31, 2023 | KDNY | ↓ Sell | 3,244 | $24.68 | $80K | Direct | Feb 2, 2023 (2d) |
| Jan 3, 2023 | KDNY | ↓ Sell | 10,000 | $25.82 | $258K | Direct | Jan 4, 2023 (1d) |
| Oct 6, 2022 | KDNY | ↓ Sell | 3,557 | $19.69 | $70K | Direct | Oct 11, 2022 (5d) |
| Aug 4, 2022 | KDNY | ↓ Sell | 5,000 | $20.00 | $100K | Direct | Aug 5, 2022 (1d) |
| Jul 11, 2022 | KDNY | ↓ Sell | 5,000 | $18.09 | $90K | Direct | Jul 13, 2022 (2d) |
| Apr 11, 2022 | KDNY | ↓ Sell | 5,000 | $15.36 | $77K | Direct | Apr 13, 2022 (2d) |
| Feb 18, 2022 | KDNY | ↓ Sell | 2,500 | $13.00 | $33K | Direct | Feb 23, 2022 (5d) |
| Feb 11, 2022 | KDNY | ↓ Sell | 2,498 | $12.74 | $32K | Direct | Feb 14, 2022 (3d) |
| Feb 10, 2022 | KDNY | ↓ Sell | 2,500 | $13.31 | $33K | Direct | Feb 11, 2022 (1d) |
| Nov 9, 2021 | KDNY | ↓ Sell | 5,000 | $13.53 | $68K | Direct | Nov 12, 2021 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Andrew James King's insider trades
Andrew James King is Chief Scientific Officer at Chinook Therapeutics (KDNY). Since Nov 9, 2021, Andrew has reported no open-market purchases and 13 sales worth $1.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (13 filings), grants and awards (7 filings), shares returned to the company (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KDNY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.